Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson, Ulrich Knigge, Gitte Dam, Birgitte Federspiel, Henning Grønbaek, Peter Stålberg, Seppo W Langer, Andreas Kjaer, Johanna Arola, Camilla Schalin-Jäntti, Anders Sundin, Staffan Welin, Espen Thiis-Evensen, Halfdan Sorbye

Abstract

BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.

AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

Original languageEnglish
JournalActa Oncologica
Volume60
Issue number7
Pages (from-to)931-941
Number of pages11
ISSN0284-186X
DOIs
Publication statusPublished - Jul 2021

Keywords

  • Gastrointestinal Neoplasms
  • Humans
  • Intestinal Neoplasms/diagnosis
  • Neuroendocrine Tumors/diagnosis
  • Pancreatic Neoplasms/diagnosis
  • Stomach Neoplasms/diagnosis

Fingerprint

Dive into the research topics of 'Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms'. Together they form a unique fingerprint.

Cite this